LOGIN
Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis
September 2022
Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Randomized controlled trial of suprascapular nerve blocks for subacute adhesive capsulitis
Eur J Phys Rehabil Med . 2022 Aug;58(4):630-637.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-five patients with subacute adhesive capsulitis were randomized to receive either a suprascapular nerve block with ropivacaine (n=19) or saline (n=16). The primary outcome of this trial was shoulder function using the Constant-Murley Score after 4 weeks. Secondary outcomes assessed range of motion and shoulder pain intensity 4 weeks after the last injection. No significant differences were ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.